Long acting sustained-release formulation containing dopamine receptor agonist and the preparation method thereof

Details for Australian Patent Application No. 2005287743 (hide)

Owner Shandong Luye Pharmaceutical Co., Ltd.

Inventors Zhang, Luping

Agent Davies Collison Cave

Pub. Number AU-B-2005287743

PCT Pub. Number WO2006/032202

Priority 200410077961.9 21.09.04 CN

Filing date 21 September 2005

Wipo publication date 30 March 2006

Acceptance publication date 29 September 2011

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/381 (2006.01) - having five-membered rings

A61K 47/30 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

Event Publications

19 April 2007 PCT application entered the National Phase

  PCT publication WO2006/032202 Priority application(s): WO2006/032202

29 September 2011 Application Accepted

  Published as AU-B-2005287743

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005287747-Sliding sheet type of variable-teeth gear

2005287738-Method for treating biomass and organic waste with the purpose of generating desired biologically based products